Pharmaceutical sector shares fall after price control order

Prices of 348 essential medicines will come down in the state, thanks to a new drug price control order by the Department of Pharmaceuticals. Sources say the prices of these drugs will be reduced by as much as 10-20 per cent, once the new pricing ...

There is no classification as life saving drugs/medicines under Drugs (Prices Control) Order, 1995 (DPCO, 1995). Under the provisions of the DPCO, 1995, the prices of 74 scheduled bulk drugs and the formulations containing any of these scheduled ...

The domestic pharmaceutical market is expected to witness value erosion of around Rs 1,600 crore due to the Drug Price Control Order (DPCO) 2013, to take effect by the first week of July, at the latest. The existing order it replaces dates back to ...

With about three-fourth of Indians spending their own money for medical treatment, this must be great news. But in reality, it's not; instead it's a wasted opportunity which perhaps has been dictated by the interests of the pharma lobby. Getty Image ...

The Supreme Court decision denying Novartis a patent for the cancer drug imanitib has been hailed as a victory for the affordable medicines movement. But it won't make much difference if doctors continue to prescribe expensive branded drugs, ...

The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world's poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major ...

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has denied a price rise for some imported products of Sanofi, Novartis, and Allergan. In a meeting earlier this month, the regulator rejected price revision applications for ...

The department of pharmaceuticals turned down a review petition by drugmaker Cipla against a price fixation order by the National Pharmaceutical Pricing Authority, slashing the price of Dytor Plus, a medicine for kidney and heart ailments. DoP said since the company had not informed whether the price fixed had been implemented, there was no question of a review. It has asked the regulator to recover if there is any amount overcharged by the firm on sales of the drug.“Based on the record ...

The Indian pharmaceutical market size in terms of value will likely come down by Rs.1,600 crore C.H. Unnikrishnan Drug makers have 45 days from the date of the notification of the new rules to introduce the newly priced medicine packs. The drugs ...